863237-47-2

Upstream product

• 863237-46-1 (1R,2R)-1-(3'-benzyloxyphenyl)-3-(2''-hydroxy-4'',6''-dibenzyloxyphenyl)propane-1,2-diol 
• 149-73-5 trimethyl orthoformate 
• 63604-98-8 1,3-dibenzylphloroglucinol 
• 59434-20-7 1,3,5-tri-O-benzylphloroglucinol 
• 850307-91-4 (E)-3-[2,4-bis(benzyloxy)-6-hydroxyphenyl]-1-(3-benzyloxyphenyl)propene 

Downstream Products

• 863237-61-0 3,4,5-Tris-benzyloxy-benzoic acid (2R,3R)-5,7-bis-benzyloxy-2-(3-benzyloxy-phenyl)-chroman-3-yl ester 

Relevant academic research and scientific papers

Asymmetric total synthesis of B-ring modified (-)-epicatechin gallate analogues and their modulation of β-lactam resistance in Staphylococcus aureus

Two enantiomerically pure B-ring modified analogues of (-)-epicatechin gallate were synthesised and their modulation of β-lactam resistance using three strains of methicillin resistant Staphylococcus aureus (BB 568, EMRSA-15 and EMRSA-16) evaluated. Sub-i

Structure-activity study of epi-gallocatechin gallate (EGCG) analogs as proteasome inhibitors

The structure-activity relationship of a number of synthetic green tea polyphenol analogs involving modifications of A ring and B ring of epi-gallocatechin gallate (EGCG) as proteasome inhibitors has been examined. It was found that in B ring, a decrease in the number of OH groups led to decreased potency. Introduction of a hydrophobic benzyl group into the 8 position of A ring did not significantly affect the proteasome-inhibitory potency.